The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be ...

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...

Malignant testicular germ cell tumors are the most common cancers diagnosed in males ages 15 to 39 in the U.S., though ...

Moving beyond the traditional sputum tests, a new study on Friday showed that a molecular stool test may increase detection ...

The Centre for Cellular and Molecular Biology (CCMB) has partnered with the Tata Steel Foundation (TSF) and the National Health Mission (NHM), Jharkhand, to launch a large-scale sickle cell anemia ...

The global oncology blood testing market is on the brink of a major transformation, with projections indicating a significant rise from USD 3,851.7 million in 2022 to USD 18,278.2 million by 2032.

The CSIR-Centre for Cellular and Molecular Biology has teamed with Tata Trust Foundation and the National Health Mission to ...

The Centre for Cellular and Molecular Biology (CCMB), an autonomous institute under the Council of Scientific and Industria ...

In the growing field of personalized medicine, scientists at Yale University have found promising evidence that a simple ...